India Glycols Limited has established a Committee of Directors to lead a comprehensive review of its corporate strategy. The committee will evaluate various strategic options, including potential business restructuring, to enhance competitiveness and unlock shareholder value.
The review is driven by an evolving business environment and the emergence of new market opportunities. The committee is authorized to engage external experts and consultants to assist in the evaluation process.
Upon completion, the committee will present its formal recommendations to the Board of Directors. India Glycols currently operates across several segments, including Bio-based Specialties, Performance Chemicals, Potable Spirits, and Ennature Bio-Pharma.